Pressrelease: InfiCure Bio secures US patent and publishes new data in a top scientific journal
https://www.mynewsdesk.com/se/umeaa-biotech-incubator/pressreleases/inficure-bio-secures-us-patent-and-publishes-new-data-in-a-top-scientific-journal-3060618?utm_source=rss&utm_medium=rss&utm_campaign=Alert&utm_content=pressrelease
New publication on the liver phenotype of the NIF mouse
Check out our new exciting study describing the liver phenotype of the NIF mouse! We are proud to announce that it has been accepted for publication in Scientific Reports (https://lnkd.in/emhf8h7). In this paper we demonstrate [...]
InfiCure Bio will attend the annual NASH Summit in mid December
InfiCure Bio AB will attend the 4th NASH Summit (https://nash-summit.com) in mid December and our CEO Sofia Mayans will give a talk on our unique NIF mouse on December 16th at 2.45pm EST. Do not [...]
InfiCure Bio attends AFDD November 16-18
Sofia Mayans and Dan Holmberg will attend the Annual AFDD meeting, this year an entirely digital event: https://afdd-summit.com/
Autumn is here and the future is bright!
The annual retreat for InfiCure Bio took place last week and we had fruitful and interesting discussions on future progress of the company. Validation of the NIF mouse as a spontaneous liver model is complete [...]
Thesis defense
Julia Nilsson will defend her thesis "Cellular and molecular mechanisms in immune mediated hepatic fibrosis. A study of the inflammatory and fibrosis development of the NIF mouse liver" on Friday May 15th at 9.15 CET. [...]